Quick Answer
PUMA BIOTECHNOLOGY, INC. reported Total Assets of $216.30 million for the year ending 2025.
- PUMA BIOTECHNOLOGY, INC. showed an increase of +1.4% in Total Assets from 2024 to 2025.
- This data is from PUMA BIOTECHNOLOGY, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2010: $462.00 | Q2 2011: $1.7 thousand | Q3 2011: $38.4 thousand | Q1 2012: $52.82 million | Q2 2012: $44.44 million | Q3 2012: $36.50 million | Q1 2013: $141.02 million | Q2 2013: $127.98 million | Q3 2013: $115.11 million | Q1 2014: $220.25 million | Q2 2014: $196.08 million | Q3 2014: $172.05 million | Q1 2015: $331.88 million | Q2 2015: $302.36 million | Q3 2015: $271.62 million | Q1 2016: $205.17 million | Q2 2016: $170.89 million | Q3 2016: $134.03 million | Q1 2017: $216.62 million | Q2 2017: $172.82 million | Q3 2017: $181.86 million | Q1 2018: $169.64 million | Q2 2018: $227.62 million | Q3 2018: $230.72 million | Q1 2019: $331.36 million | Q2 2019: $239.86 million | Q3 2019: $232.04 million | Q1 2020: $225.53 million | Q2 2020: $263.81 million | Q3 2020: $261.70 million | Q1 2021: $258.66 million | Q2 2021: $260.00 million | Q3 2021: $226.29 million | Q1 2022: $200.69 million | Q2 2022: $193.65 million | Q3 2022: $198.77 million | Q1 2023: $196.26 million | Q2 2023: $200.49 million | Q3 2023: $203.61 million | Q1 2024: $214.15 million | Q2 2024: $205.00 million | Q3 2024: $220.72 million | Q1 2025: $196.18 million | Q2 2025: $194.92 million | Q3 2025: $202.86 million.
- Over the full 15 years of available data (2011 to 2025), PUMA BIOTECHNOLOGY, INC.'s Total Assets has grown by 290.5%.
- Historical annual values: Fiscal year 2025: $216.30 million | Fiscal year 2024: $213.33 million | Fiscal year 2023: $230.53 million | Fiscal year 2022: $222.06 million | Fiscal year 2021: $226.59 million | Fiscal year 2020: $244.22 million | Fiscal year 2019: $234.91 million | Fiscal year 2018: $259.12 million | Fiscal year 2017: $165.53 million | Fiscal year 2016: $252.79 million | Fiscal year 2015: $239.84 million | Fiscal year 2014: $162.76 million | Fiscal year 2013: $104.37 million | Fiscal year 2012: $151.70 million | Fiscal year 2011: $55.40 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: